RIPK3 and metabolic dysfunction-associated steatohepatitis: In contrast, MLKL, but not RIP3, was higher in patients with MASH activity score (NAS) ≥ 3 compared to patients with NAS < 3 (Miyata et al, 2021), suggesting circulating MLKL in patients with MASH is reflective of disease severity.